Myasthenia gravis

From IDWiki
Revision as of 17:02, 17 February 2026 by Aidan (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Definition

  • A autoimmune disorder of the motor endplate that is associated with thymomas and causes a syndrome of weakness that worsens with repeated movements
  • Can also present with predominantly bulbar involvement, or simple ocular involvement

Clinical Manifestations

  • History
  • Signs & Symptoms
    • Ptosis worse than baseline
    • Abnormal or fatiguable extraocular movements
    • Dysarthria
    • Neck flexion and extension (tests C3-4 that also innervates the diaphragm)
    • Decreased duration of limb raiding

Management

  • Acute
    • Monitor FVC, MIPS, and MEPS
      • Can approximate FVC by counting the duration of exhilation
  • Chronic

Avoidance of Certain Medications

  • Some medications are thought to cause or exacerbate myasthenic crisis through a variety of mechanisms1
  • Altered immune response:
  • Effects on neuromuscular transmission:
    • Definite association with macrolides, aminoglycosides, class Ia antiarrhythmics, magnesium, neuromuscular blockers and inhaled anaesthetics, corticosteroids (use low doses when possible), botulinum toxin
    • Probable association with fluoroquinolones, penicillins (rare), lithium
    • Possible association with beta blockers, L-type CCBs, antipsychotics
  • The above antibiotics can be used if necessary, but may need close clinical monitoring

References

  1. ^  Shuja Sheikh, Usman Alvi, Betty Soliven, Kourosh Rezania. Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update. Journal of Clinical Medicine. 2021;10(7):1537. doi:10.3390/jcm10071537.